Newstral
Article
bizjournals.com on 2016-11-02 22:46
Former Sprout shareholders sue Valeant over female libido drug marketing
Related news
- Sprout shareholders get their female libido pill back from Valeantnewsobserver.com
- Valeant to spend about $1B on Sprout, maker of women's libido drugWRAL
- Valeant to buy maker of libido drug for $1BThe Salt Lake Tribune
- Valeant Pharmaceuticals signs deal to sell Sprout Pharmaceuticals unitThe Globe and Mail
- Some Valeant shareholders swap stakes for ones in female libido drugbizjournals.com
- Valeant to spend about $1B on maker of women's libido drugabqjournal.com
- Valeant to spend about $1B on maker of women’s libido drugwkrg.com
- Ex-Viacom shareholders can sue Shari Redstone over ViacomCBS mergerNew York Post
- Valeant Nears Deal for Libido Drugwsj.com
- NMSG shareholders sue James Dolan over high salary, excessive time with his bandnypost.com
- Shareholders sue Vivendi Universalnwaonline.com
- Shareholders sue MoviePass parentbizjournals.com
- Valeant nears deal for ‘female Viagra’ maker Sprout: reportThe Globe and Mail
- WValeant CEO meets with shareholders at AGMwhitecourtpress.com
- WSJ: Valeant To Acquire Libido Pill Maker For $1 BillionForbes
- Video: Valeant pays $1-billion for 'female Viagra' maker SproutThe Globe and Mail
- SPROUTmcall.com